The ABC-Type Efflux Pump MacAB Protects Salmonella enterica serovar Typhimurium from Oxidative Stress
暂无分享,去创建一个
H. Andrews-Polymenis | A. Vázquez-Torres | L. Bogomolnaya | A. Maple | Yury Ragoza | K. D. Andrews | Marissa Talamantes
[1] J. Martínez,et al. RND multidrug efflux pumps: what are they good for? , 2013, Front. Microbio..
[2] I. Lasa,et al. Effect of Transcriptional Activators SoxS, RobA, and RamA on Expression of Multidrug Efflux Pump AcrAB-TolC in Enterobacter cloacae , 2012, Antimicrobial Agents and Chemotherapy.
[3] A. Nusrat,et al. Enteric Commensal Bacteria Induce Extracellular Signal-regulated Kinase Pathway Signaling via Formyl Peptide Receptor-dependent Redox Modulation of Dual Specific Phosphatase 3* , 2011, The Journal of Biological Chemistry.
[4] F. Fang. Antimicrobial Actions of Reactive Oxygen Species , 2011, mBio.
[5] A. Yamaguchi,et al. Regulation of the AcrAB multidrug efflux pump in Salmonella enterica serovar Typhimurium in response to indole and paraquat. , 2011, Microbiology.
[6] J. Imlay,et al. The SoxRS response of Escherichia coli is directly activated by redox‐cycling drugs rather than by superoxide , 2011, Molecular microbiology.
[7] B. McCollister,et al. Nitric Oxide Protects Bacteria from Aminoglycosides by Blocking the Energy-Dependent Phases of Drug Uptake , 2011, Antimicrobial Agents and Chemotherapy.
[8] K. Poole,et al. Oxidative Stress Induction of the MexXY Multidrug Efflux Genes and Promotion of Aminoglycoside Resistance Development in Pseudomonas aeruginosa , 2010, Antimicrobial Agents and Chemotherapy.
[9] G. Klein,et al. Decreased fluoroquinolone susceptibility in mutants of Salmonella serovars other than Typhimurium: detection of novel mutations involved in modulated expression of ramA and soxS. , 2009, The Journal of antimicrobial chemotherapy.
[10] D. Landman,et al. Correlation of the expression of acrB and the regulatory genes marA, soxS and ramA with antimicrobial resistance in clinical isolates of Klebsiella pneumoniae endemic to New York City. , 2009, The Journal of antimicrobial chemotherapy.
[11] S. Porwollik,et al. Analysis of Pools of Targeted Salmonella Deletion Mutants Identifies Novel Genes Affecting Fitness during Competitive Infection in Mice , 2009, PLoS pathogens.
[12] M. Morikawa,et al. Flexible exportation mechanisms of arthrofactin in Pseudomonas sp. MIS38 , 2009, Journal of applied microbiology.
[13] A. Yamaguchi,et al. Regulation and physiological function of multidrug efflux pumps in Escherichia coli and Salmonella. , 2009, Biochimica et biophysica acta.
[14] T. Tsuchiya,et al. Multidrug efflux transporters in the MATE family. , 2009, Biochimica et biophysica acta.
[15] S. Yaron,et al. Regulation of marA, soxS, rob, acrAB and micF in Salmonella enterica serovar Typhimurium , 2008, Microbiology and immunology.
[16] H. Andrews-Polymenis,et al. ‘Form variation’ of the O12 antigen is critical for persistence of Salmonella Typhimurium in the murine intestine , 2008, Molecular microbiology.
[17] E. Takahashi,et al. MacAB Is Involved in the Secretion of Escherichia coli Heat-Stable Enterotoxin II , 2008, Journal of bacteriology.
[18] A. Dinner,et al. The Pseudomonas aeruginosa multidrug efflux regulator MexR uses an oxidation-sensing mechanism , 2008, Proceedings of the National Academy of Sciences.
[19] A. Yamaguchi,et al. AcrAB Multidrug Efflux Pump Regulation in Salmonella enterica serovar Typhimurium by RamA in Response to Environmental Signals , 2008, Journal of Biological Chemistry.
[20] W. Stiekema,et al. Genetic and functional characterization of the gene cluster directing the biosynthesis of putisolvin I and II in Pseudomonas putida strain PCL1445. , 2008, Microbiology.
[21] J. Imlay. Cellular defenses against superoxide and hydrogen peroxide. , 2008, Annual review of biochemistry.
[22] R. Pridmore,et al. Hydrogen peroxide production by Lactobacillus johnsonii NCC 533 and its role in anti-Salmonella activity. , 2008, FEMS microbiology letters.
[23] M. Parker,et al. During infection of epithelial cells Salmonella enterica serovar Typhimurium undergoes a time-dependent transcriptional adaptation that results in simultaneous expression of three type 3 secretion systems , 2008, Cellular microbiology.
[24] M. Toledano,et al. ROS as signalling molecules: mechanisms that generate specificity in ROS homeostasis , 2007, Nature Reviews Molecular Cell Biology.
[25] A. Driessen,et al. Distribution and Physiology of ABC-Type Transporters Contributing to Multidrug Resistance in Bacteria , 2007, Microbiology and Molecular Biology Reviews.
[26] H. Wexler,et al. Bile salts enhance bacterial co-aggregation, bacterial-intestinal epithelial cell adhesion, biofilm formation and antimicrobial resistance of Bacteroides fragilis. , 2007, Microbial pathogenesis.
[27] Dongwoo Shin,et al. A Positive Feedback Loop Promotes Transcription Surge That Jump-Starts Salmonella Virulence Circuit , 2006, Science.
[28] J. Mekalanos,et al. Characterization of the Vibrio cholerae vexAB and vexCD efflux systems , 2006, Archives of Microbiology.
[29] T. Latifi,et al. Virulence and drug resistance roles of multidrug efflux systems of Salmonella enterica serovar Typhimurium , 2006, Molecular microbiology.
[30] Jun Lin,et al. Bile Salts Modulate Expression of the CmeABC Multidrug Efflux Pump in Campylobacter jejuni , 2005, Journal of bacteriology.
[31] W. Shafer,et al. Characterization of the MacA-MacB efflux system in Neisseria gonorrhoeae. , 2005, The Journal of antimicrobial chemotherapy.
[32] S. Peña-Llopis,et al. Constitutive soxR Mutations Contribute to Multiple-Antibiotic Resistance in Clinical Escherichia coli Isolates , 2005, Antimicrobial Agents and Chemotherapy.
[33] J. Imlay,et al. Substantial DNA damage from submicromolar intracellular hydrogen peroxide detected in Hpx- mutants of Escherichia coli. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[34] D. Hooper. Efflux pumps and nosocomial antibiotic resistance: a primer for hospital epidemiologists. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[35] Canghai Lu,et al. Quantitative and kinetic study of oxidative stress regulons using green fluorescent protein. , 2005, Biotechnology and bioengineering.
[36] J. Imlay,et al. Are Respiratory Enzymes the Primary Sources of Intracellular Hydrogen Peroxide?* , 2004, Journal of Biological Chemistry.
[37] F. Fang. Antimicrobial reactive oxygen and nitrogen species: concepts and controversies , 2004, Nature Reviews Microbiology.
[38] H. Nikaido,et al. Bile salts and fatty acids induce the expression of Escherichia coli AcrAB multidrug efflux pump through their interaction with Rob regulatory protein , 2003, Molecular microbiology.
[39] M. Hogardt,et al. Pretreatment of Mice with Streptomycin Provides a Salmonella enterica Serovar Typhimurium Colitis Model That Allows Analysis of Both Pathogen and Host , 2003, Infection and Immunity.
[40] Arthur Thompson,et al. Unravelling the biology of macrophage infection by gene expression profiling of intracellular Salmonella enterica , 2002, Molecular microbiology.
[41] P. Youderian,et al. The Salmonella enterica sv. Typhimurium smvA, yddG and ompD (porin) genes are required for the efficient efflux of methyl viologen , 2002, Molecular microbiology.
[42] J. Imlay,et al. Alkyl Hydroperoxide Reductase Is the Primary Scavenger of Endogenous Hydrogen Peroxide in Escherichia coli , 2001, Journal of bacteriology.
[43] J. Imlay,et al. Hydrogen Peroxide Fluxes and Compartmentalization inside Growing Escherichia coli , 2001, Journal of bacteriology.
[44] R. L. Santos,et al. Animal models of Salmonella infections: enteritis versus typhoid fever. , 2001, Microbes and infection.
[45] A. Yamaguchi,et al. Novel Macrolide-Specific ABC-Type Efflux Transporter inEscherichia coli , 2001, Journal of bacteriology.
[46] M H Saier,et al. The drug/metabolite transporter superfamily. , 2001, European journal of biochemistry.
[47] S. Levy,et al. A soxRS-Constitutive Mutation Contributing to Antibiotic Resistance in a Clinical Isolate of Salmonella enterica (Serovar Typhimurium) , 2001, Antimicrobial Agents and Chemotherapy.
[48] Corinaldesi,et al. Role of antibiotic therapy on long‐term germ excretion in faeces and digestive symptoms after Salmonella infection , 2000, Alimentary pharmacology & therapeutics.
[49] B. Wanner,et al. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[50] F. Fang,et al. Salmonella pathogenicity island 2-dependent evasion of the phagocyte NADPH oxidase. , 2000, Science.
[51] M H Saier,et al. The RND permease superfamily: an ancient, ubiquitous and diverse family that includes human disease and development proteins. , 1999, Journal of molecular microbiology and biotechnology.
[52] P. Garner,et al. Antibiotics for treating salmonella gut infections. , 1999, The Cochrane database of systematic reviews.
[53] N. Ganguly,et al. Role of reactive oxygen species in Salmonella typhimurium-induced enterocyte damage. , 1998, Scandinavian journal of gastroenterology.
[54] I. Paulsen,et al. Major Facilitator Superfamily , 1998, Microbiology and Molecular Biology Reviews.
[55] B. Finlay,et al. Murine Salmonellosis Studied by Confocal Microscopy: Salmonella typhimurium Resides Intracellularly Inside Macrophages and Exerts a Cytotoxic Effect on Phagocytes In Vivo , 1997, The Journal of experimental medicine.
[56] R. L. Lucas,et al. Co‐ordinate regulation of Salmonella typhimurium invasion genes by environmental and regulatory factors is mediated by control of hilA expression , 1996, Molecular microbiology.
[57] T. Hill,et al. Insertion of inverted Ter sites into the terminus region of the Escherichia coli chromosome delays completion of DNA replication and disrupts the cell cycle , 1995, Molecular microbiology.
[58] D. Hinshaw,et al. Hydrogen peroxide as a potent bacteriostatic antibiotic: implications for host defense. , 1995, Free radical biology & medicine.
[59] H. Bremer,et al. Control of the Escherichia coli rrnB P1 promoter strength by ppGpp , 1995, The Journal of Biological Chemistry.
[60] J. Hearst,et al. Genes acrA and acrB encode a stress‐induced efflux system of Escherichia coli , 1995, Molecular microbiology.
[61] H. Voet,et al. Increased neutrophil chemiluminescence production in patients with cystic fibrosis. , 1994, Metabolism: clinical and experimental.
[62] H. Nikaido,et al. Prevention of drug access to bacterial targets: permeability barriers and active efflux. , 1994, Science.
[63] E. Cobo,et al. Ciprofloxacin and trimethoprim-sulfamethoxazole versus placebo in acute uncomplicated Salmonella enteritis: a double-blind trial. , 1993, The Journal of infectious diseases.
[64] P. Heisig. High-level fluoroquinolone resistance in a Salmonella typhimurium isolate due to alterations in both gyrA and gyrB genes. , 1993, The Journal of antimicrobial chemotherapy.
[65] F. Heffron,et al. Recombination‐deficient mutants of Salmonella typhimurium are avirulent and sensitive to the oxidative burst of macrophages , 1993, Molecular microbiology.
[66] P. Rather,et al. Molecular genetics of aminoglycoside resistance genes and familial relationships of the aminoglycoside-modifying enzymes. , 1993, Microbiological reviews.
[67] S. Levy,et al. Active efflux mechanisms for antimicrobial resistance , 1992, Antimicrobial Agents and Chemotherapy.
[68] S. Opal,et al. Failure of ciprofloxacin to eradicate convalescent fecal excretion after acute salmonellosis: experience during an outbreak in health care workers. , 1991, Annals of internal medicine.
[69] J. Galán,et al. Expression of Salmonella typhimurium genes required for invasion is regulated by changes in DNA supercoiling , 1990, Infection and immunity.
[70] B. Bloom,et al. Regulation of macrophage function by interferon-gamma. Somatic cell genetic approaches in murine macrophage cell lines to mechanisms of growth inhibition, the oxidative burst, and expression of the chronic granulomatous disease gene. , 1990, The Journal of clinical investigation.
[71] S. Miller,et al. A two-component regulatory system (phoP phoQ) controls Salmonella typhimurium virulence. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[72] J. Galán,et al. Virulence and vaccine potential of phoP mutants of Salmonella typhimurium. , 1989, Microbial pathogenesis.
[73] F. Heffron,et al. Intracellular survival of wild-type Salmonella typhimurium and macrophage-sensitive mutants in diverse populations of macrophages , 1989, Infection and immunity.
[74] C. Nathan. Neutrophil activation on biological surfaces. Massive secretion of hydrogen peroxide in response to products of macrophages and lymphocytes. , 1987, The Journal of clinical investigation.
[75] C. Haidaris,et al. Mutants of Salmonella typhimurium that cannot survive within the macrophage are avirulent. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[76] D. Hooper,et al. The fluoroquinolones: pharmacology, clinical uses, and toxicities in humans , 1985, Antimicrobial Agents and Chemotherapy.
[77] I. Fridovich,et al. Effects of molecular oxygen on detection of superoxide radical with nitroblue tetrazolium and on activity stains for catalase. , 1984, Analytical biochemistry.
[78] Y. Chabbert,et al. Role of porin proteins OmpF and OmpC in the permeation of beta-lactams , 1982, Antimicrobial Agents and Chemotherapy.
[79] W. Soeller,et al. Macrophage variants in oxygen metabolism , 1980, The Journal of experimental medicine.
[80] J. Nelson,et al. Treatment of Salmonella gastroenteritis with ampicillin, amoxicillin, or placebo. , 1980, Pediatrics.
[81] J. Carlsson,et al. The recA+ gene product is more important than catalase and superoxide dismutase in protecting Escherichia coli against hydrogen peroxide toxicity , 1980, Journal of bacteriology.
[82] H. Hsu,et al. The comparative histopathology of primary and secondary lesions in murine salmonellosis. , 1980, British journal of experimental pathology.
[83] V. McGovern,et al. Pathology of salmonella colitis , 1979, The American journal of surgical pathology.
[84] Mcgovern Vj,et al. Pathology of salmonella colitis. , 1979 .
[85] D. W. Day,et al. The rectal biopsy appearances in Salmonella colitis , 1978, Histopathology.
[86] J. Bennett,et al. Effect of antibiotic therapy in acute salmonellosis on the fecal excretion of salmonellae. , 1969, The New England journal of medicine.